Hi Wombat,
Appreciate all your work.
The price per dose of 70k I think is very conservative, I think 100k to 150k is more realistic for US based on the costs that seem to be 500k-1,200k per stay for sever cases, Also for the people that don't make it, but would if given our treatment, that lost cost has to be factored in to the savings to the health funds. Not just the reduction in stay/cost for the ones that make it. Also the ongoing cost after an infection with all the complications in heart and other organs.
Speculative 8-month target - $33.00 MSB for GVHD, COVID ARDS, page-24
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |